Official Journal of the Italian Society of Orthopaedics and Traumatology
Author | Follow up (months) | Age (years) | Male (%) | N | Complication | |
---|---|---|---|---|---|---|
Yes | No | |||||
Stam L | 46.8 | 40 | 73.9 | 23 | 0 | 23 |
Dimakopoulos P | 33.2 | 33.5 | 91.2 | 15 | 2 | 32 |
Ryhanen J | 12 | 37 | – | 15 | 1 | 14 |
Choi S | 41.2 | 33.5 | 80 | 26 | 1 | 19 |
Murena L | 31 | 33.3 | 93.8 | 16 | 2 | 14 |
Greiner S | 70 | 35.3 | 86 | 50 | 4 | 46 |
Salzmann GM | 24 | 37.5 | 91.3 | 23 | 1 | 22 |
Scheibel M | 26.5 | 38.6 | 92.9 | 37 | 0 | 40 |
Wai HF | 12 | 42.8 | 86.7 | 15 | 2 | 13 |
El Sallakh SA | 24 | 30 | 90 | 10 | 0 | 10 |
Sandmann GH | 32 | 39 | 91 | 33 | 3 | 30 |
Beris A | 18.25 | 27.5 | 75 | 12 | 0 | 12 |
Kranus N | 24 | 37.7 | 93.3 | 15 | 0 | 13 |
Kranus N | 24 | 40.9 | 92.3 | 13 | 1 | 14 |
Venjakob AJ | 58 | – | 91.3 | 23 | 2 | 21 |
Spolitil M | 5 | 33 | 84.2 | 19 | 3 | 16 |
Acar MA | 13.6 | 43.4 | 92.3 | 13 | 1 | 12 |
Katsenis DL | 42 | 35.5 | 76 | 50 | 6 | 50 |
Pan Z | 24 | 26 | 72.7 | 22 | 2 | 20 |
Shin SJ | 25.6 | 45.4 | 94.4 | 18 | 8 | 10 |
Struhl S | 62.4 | 45.7 | 88.9 | 9 | 4 | 5 |
Escher A | 31.2 | 42.3 | 88.5 | 52 | 0 | 25 |
Andreani L | 3 | – | 100 | 28 | 2 | 17 |
Jensen G | 48 | 39 | 91.1 | 56 | 12 | 14 |
Metzlaff S | 32 | 37.6 | 79.5 | 44 | 1 | 23 |
Yoon JP | – | 40 | 78.6 | 42 | 6 | 12 |
Pooled prevalence LSF (95% CI) | 0.08 (0.06, 0.10) | Â | Â | |||
Koukakis A | 10.6 | – | – | 16 | 0 | 16 |
Salem KH | 30 | 41 | 92 | 23 | 7 | 16 |
Kienast B | 36 | 38.4 | – | 225 | 24 | 201 |
Francesco AD | 12 | 27.5 | 66.7 | 42 | 5 | 37 |
Sarrafan N | 12 | 38 | 90 | 30 | 1 | 29 |
Escher A | 31.2 | 42.3 | 88.5 | 52 | 5 | 22 |
Guizzi P | 21 | – | – | 12 | 1 | 1 |
Gille J | 7 | – | – | 3 | 0 | 3 |
Heideken JV | 32 | 40 | 77.3 | 19 | 0 | 19 |
Andreani L | 3 | – | 100 | 28 | 0 | 7 |
Jensen G | 48 | 39 | 91.1 | 56 | 19 | 11 |
Metzlaff S | 32 | 37.6 | 79.5 | 44 | 0 | 20 |
Steinbacher G | 50.4 | 29 | 73.7 | 19 | 0 | 19 |
Jafary D | 19 | 40.3 | 91.7 | 24 | 2 | 22 |
Kumar N | 23.5 | 34.24 | 100 | 33 | 0 | 33 |
Yoon JP | – | 40 | 78.6 | 42 | 9 | 15 |
Pooled prevalence HP (95% CI) | 0.05 (0.02, 0.08) | Â | Â | |||
RR of LSF vs HPÂ | 1.69 (1.07, 2.60) | Â | Â |